Published in Surgery Litigation and Law Weekly, February 2nd, 2007
This trend article about DHZB, Berlin, Germany, is an immediate alert from NewsRx to identify developing directions of research.
Study 1: A first experience with oral combination therapy with bosentan and sildenafil for pulmonary arterial hypertension proved to be safe and effective.
According to recent research published in the European Journal of Clinical Investigation, "New oral substances such as beraprost, bosentan and sildenafil have proven effective in different forms of pulmonary arterial hypertension (PAH), both alone and in combination with standard...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.